Article Text

Retrospective evaluation of the long-term outcome of non-surgical management of 74 dogs with clinical hip dysplasia
  1. M. Farrell, BVetMed, CertVA, CertSAS, MRCVS1,
  2. D. N. Clements, BVSc, BSc, DipECVS, DSAS(Orth), MRCVS1,
  3. D. Mellor, BVMS, PhD, DipECVPH1,
  4. T. Gemmill, BVSc, MVM, DipECVS, DSAS(Orth), MRCVS1,
  5. S. P. Clarke, BVMS, DSAS(Orth), DipECVS, MRCVS1,
  6. J. L. Arnott, BVMS, CertSAS, MRCVS1,
  7. D. Bennett, BSc, BVetMed, PhD, DSAO, ILTM, MRCVS1 and
  8. S. Carmichael, BVMS, MVM, DSAO, MRCVS1
  1. 1 Department of Veterinary Clinical Studies, University of Glasgow, Bearsden Road, Glasgow G61 1QH
  1. Mr Clements's present address is Musculoskeletal Diseases Research Group, Faculty of Veterinary Science, University of Liverpool, Liverpool L7 7EX


The long-term outcome for dogs treated non-surgically for clinical signs of canine hip dysplasia were evaluated retrospectively; 74 dogs were evaluated by a postal questionnaire sent to their owners, and 24 of these were also evaluated by a veterinary clinical examination. A total of 11 outcome variables were evaluated. Depending on the variable assessed, between 31 (41·9 per cent) and 49 (66·2 per cent) of the dogs remained clinically affected according to their owner's assessment, and between 17 (70·8 per cent) and 23 (95·8 per cent) of the 24 dogs had abnormalities attributed to hip osteoarthritis according to the veterinary assessment. Orthopaedic abnormalities other than hip dysplasia affected 17 of the 24 dogs. Long-term medications had been prescribed for the treatment of clinical signs associated with hip dysplasia in 41 of the 74 dogs.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.